Johnson & Johnson Submits Single-dose COVID-19 Vaccine Candidate to FDA for Emergency Use Authorization

Johnson & Johnson Submits Single-dose COVID-19 Vaccine Candidate to FDA for Emergency Use Authorization

(Fox Business) On Thursday, February 4, Johnson & Johnson submitted its single-dose vaccine to the FDA for emergency use authorization. If approved, this will be a third vaccine option available. As of last week, the vaccine was about 72% effective. Click Here to read more.